Profile
Ramana Kuchibhatla is the founder of QED Pharmaceutical Services LLC.
Dr. Kuchibhatla is currently Senior Vice President, Head-Research & Development at Minerva Neurosciences, Inc. since 2021.
Former positions include Executive Director-Global Drug Development at PRA Health Sciences, Inc., Senior Director-Clinical Research & Development at Targacept, Inc., and Senior Vice President-Clinical Developments at Melior Pharmaceuticals I, Inc. Education includes undergraduate and graduate degrees from the University of Iowa.
Ramana Kuchibhatla active positions
| Companies | Position | Start |
|---|---|---|
| MINERVA NEUROSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 15/09/2021 |
Former positions of Ramana Kuchibhatla
| Companies | Position | End |
|---|---|---|
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Chief Tech/Sci/R&D Officer | - |
Melior Pharmaceuticals I, Inc.
Melior Pharmaceuticals I, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops pipeline of de-risked therapies | Chief Tech/Sci/R&D Officer | - |
QED Pharmaceutical Services LLC | Founder | - |
| PRA HEALTH SCIENCES, INC. | Corporate Officer/Principal | - |
Training of Ramana Kuchibhatla
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
PRA Health Sciences, Inc.
PRA Health Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and development services for pharmaceutical & biotechnology companies | Commercial Services |
Melior Pharmaceuticals I, Inc.
Melior Pharmaceuticals I, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops pipeline of de-risked therapies | Health Technology |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
University of Iowa
University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes drugs to treat patients suffering from central nervous system diseases | Health Technology |
QED Pharmaceutical Services LLC |
- Stock Market
- Insiders
- Ramana Kuchibhatla
















